Identification | |
---|---|
Name | Gonadorelin |
Accession Number | DB00644 (APRD01001) |
Type | small molecule |
Description | Gonadorelin is another name for gonadotropin-releasing hormone (GnRH). It is a synthetic decapeptide prepared using solid phase peptide synthesis. GnRH is responsible for the release of follicle stimulating hormone and leutinizing hormone from the anterior pitutitary. |
Structure |
|
Categories (*) | |
Molecular Weight | 1182.2901 |
Groups | approved |
Monoisotopic Weight | 1181.573025571 |
Pharmacology | |
Indication | For evaluating the functional capacity and response of the gonadotropes of the anterior pituitary also for evaluating residual gonadotropic function of the pituitary following removal of a pituitary tumor by surgery and/or irradiation. |
Mechanism of action | Systemic - Like naturally occurring gonadotropin-releasing hormone (GnRH), gonadorelin primarily stimulates the synthesis and release of luteinizing hormone (LH) from the anterior pituitary gland. Follicle-stimulating hormone (FSH) production and release is also increased by gonadorelin, but to a lesser degree. In prepubertal females and some gonadal function disorders, the FSH response may be greater than the LH response. For the treatment of amenorrhea, delayed puberty, and infertility the administration of gonadorelin is used to simulate the physiologic release of GnRH from the hypothalamus in treatment of delayed puberty, treatment of infertility caused by hypogonadotropic hypogonadism, and induction of ovulation in those women with hypothalamic amenorrhea. This results in increased levels of pituitary gonadotropins LH and FSH, which subsequently stimulate the gonads to produce reproductive steroids. |
Absorption | Rapidly absorbed when injected |
Protein binding | Not Available |
Biotransformation | Rapidly hydrolyzed to inactive peptide components |
Route of elimination | Not Available |
Toxicity | LD50>3000 mg/kg (rat, oral) |
Affected organisms |
|
Interactions | |
Drug Interactions | Not Available |
Food Interactions | Not Available |
Gonadotropin-releasing hormone receptor | |
---|---|
Name | Gonadotropin-releasing hormone receptor |
Gene Name | GNRHR |
Pharmacological action | yes |
Actions | agonist |
References |
|
DTHybrid score | 1.3256 |
Gonadotropin-releasing hormone II receptor | |
Name | Gonadotropin-releasing hormone II receptor |
Gene Name | GNRHR2 |
Pharmacological action | yes |
Actions | agonist |
References |
|
DTHybrid score | Not Available |
Id | Partner name | Gene Name | Score |
---|---|---|---|
148 | Lutropin-choriogonadotropic hormone receptor | LHCGR | 0.2629 |
3811 | Cytochrome P450 19A1 | CYP19A1 | 0.0487 |
1649 | Small inducible cytokine A2 | CCL2 | 0.0242 |
756 | Sex hormone-binding globulin | SHBG | 0.017 |
614 | Progesterone receptor | PGR | 0.0157 |
146 | Androgen receptor | AR | 0.0135 |
136 | Estrogen receptor | ESR1 | 0.0125 |
4512 | Cytochrome P450 3A4 | CYP3A4 | 0.0079 |